willdate

646 POSTS 0 COMMENTS

Gore’s Cardioform Septal Occluder reaches 10-year milestone

WL Gore & Associates has announced that its Cardioform Septal Occluder has achieved 10 years...

Young surgeons to benefit from Transatlantic grant scheme

In a joint programme between the Society of Thoracic Surgeons (STS) and the European Association...

TAVI associated with reduced odds of in-hospital mortality for bicuspid valve patients

A propensity score-matched analysis of the early outcomes of transcatheter aortic valve implantation...

Pioneering pig to human heart transplant heralded as a breakthrough

A 57-year-old patient with terminal heart disease received a successful transplant of a genetically-...

AATS and STS opt not to endorse joint coronary revascularisation guidelines

The American Association for Thoracic Surgery (AATS) and The Society of Thoracic Surgeons (STS) have...

Omicron surge sees STS move 2022 annual meeting online

The Society of Thoracic Surgeons (STS) has moved its 2022 annual meeting from an in-person to a virt...

Terumo welcomes upgraded recommendation for radial access in revascularisation guidelines

Terumo Medical Corporation has welcomed the publication of updated guidelines from the American Coll...

Robocath completes European study of robot-assisted PCI

Robocath has announced the conclusion of its R-Evolution clinical study in Europe, which was aimed a...

Impella gains a trio of regulatory approvals

Regulators in three countries have granted approvals to Impella surgical products. In the USA, the F...

Evolut PRO TAVI valve gains approval in China

Medtronic has announced that the National Medical Products Administration (NMPA) has approved th...

Cardiovascular News’ top 10 most popular stories of December 2021

The most read stories from December 2021 include analysis of the CHEETAH study and the role of mecha...

First patient enrolled in COSIRA-II trial of Neovasc Reducer

Neovasc has announced enrolment of the first patient in the COSIRA-II clinical trial. COSIRA-II (...

Endotronix announces FDA approval for PROACTIVE-HF pivotal trial design change

Endotronix has announced that the US Food and Drug Administration (FDA) has granted approval for...

Partnership to develop training system for complex valve-in-valve procedures

Biomodex and the Montreal Heart Institute (MHI, Montreal, Canada) are partnering to develop a ne...

FDA clears CavaClear IVC filter removal laser sheath

Royal Philips has announced US Food and Drug Administration (FDA) de novo clearance for the Phil...

First clinical results for Tria biopolymer valve published

Tria
Foldax has announced publication of the first clinical results for its Tria biopolymer heart val...

Sapien 3 with Alterra prestent gains FDA approval

Sapien 3
Edwards Lifesciences has received approval from the US Food and Drug Administration (FDA) for th...

Research suggests many patients may be safely discharged without opioids after cardiac surgery

Many patients undergoing cardiac surgery may be able to safely and effectively control postoperative...

EMPAKT CHF trial points to change in assessment acute heart failure patients

FAST BioMedical has announced the publication of additional results from the EMPAKT CHF (Estimating ...

Initial implants of Thubrikar TAVI system to commence

Thubrikar Aortic Valve has received approval from a Competent Authority in Poland to conduct initial...

AI improves confidence in CAD detection from a stress echocardiogram

Ultromics has announced the publication of a study assessing its EchoGo platform, powered by Art...

HeartFlow submits premarket application for coronary plaque assessment

HeartFlow has announced it has submitted a 510(k) premarket application to the US Food and Drug Admi...

“Tantalising” data open the door for further study of mechanical aspiration thrombectomy with PCI

Results of the CHEETAH clinical study highlight the potential role of mechanical aspiration thro...

Svelte Medical Systems receives US FDA approval for Slender IDS and Direct RX

Svelte Medical Systems has received US Food and Drug Administration (FDA) approval to commercialise ...

Opsens files 510(k) submission to US FDA for TAVI guidewire

Opsens has filed a 510(k) submission with the US Food & Drug Administration (FDA) for regulatory...

Joanna Chikwe appointed as editor-in-chief of The Annals of Thoracic Surgery

The Society of Thoracic Surgeons (STS) has appointed Joanna Chikwe (chair of the Department of Cardi...

Understanding the risk of acute kidney injury in the cath lab

Huge strides have been made in preventing contrast-associated acute kidney injury among patients...

Heart team approach central to updated coronary revascularisation guidelines

New guidelines for coronary artery revascularisation recommend that treatment decisions should be ba...

Coronary artery modelling technology enables 3D reconstruction of coronary vasculature

RSIP Vision has announced a new coronary artery modelling technology, which enables reconstruction o...

Philips expands cardiac ultrasound portfolio

Royal Philips has announced an expansion of its ultrasound portfolio with new imaging tools and ...

Foldax commences clinical study of Tria surgical aortic valve in India

Tria
Foldax has announced that the Drugs Controller General of India (DCGI), India’s regulatory body for ...

Venus Medtech announces Cardiovalve acquisition

Venus Medtech has announced its acquisition of Cardiovalve, a transcatheter mitral and tricuspid val...

SyMap Medical closes US$100 million financing round

SyMap Medical has announced the completion of a financing round which will be used to accelerate...

Restore Medical announces preliminary results from first-in-human use of ContraBand

Restore Medical has announced preliminary results of the first-in-human clinical trial of ContraBand...

Survey: Bullying “commonly experienced” by UK cardiology trainees

One in 10 junior doctors training to be cardiologists in the UK say they have been bullied, the resu...

Interim REVERSE-IT trial results published in NEJM Evidence

Interim results from the REVERSE-IT trial of bentracimab (PhaseBio Pharmaceuticals), which is de...

Cardiovascular News’ top 10 most popular stories of November 2021

Featuring stories from the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021, 4–6 N...

AI-based algorithm could predict outcomes after cardiac surgery

AI
A novel artificial intelligence (AI) algorithm that identifies a cardiac dysfunction from a single-l...

Soundbite Medical gains fifth US patent for its plaque modification technology

Soundbite Medical Solutions has announced that the US Patent and Trademark Office has issued a paten...

Robocath announces completion of first robotic coronary angioplasty with R-One in China

Robocath has announced the successful completion of what it has described as the first coronary angi...

TMVI is a “reproducible and reliable” tool for eliminating mitral regurgitation

Findings of the CHOICE MI registry show that transcatheter mitral valve implantation (TMVI) is a...

PCR London Valves 2021: ENVISAGE TAVI AF and the future of TAVI trials

TAVI
Findings from an on-treatment major bleeding analysis from the ENVISAGE TAVI AF trial, presented...

Mirvat Alasnag

Mirvat Alasnag is the Gulf region’s first female interventional cardiologist. Currently the director...

CSI recalls Wirion embolic protection device

Cardiovascular Systems has initiated a voluntary recall of unused Wirion embolic protection systems ...

PCR London Valves: Two-year GALILEO data show comparable outcomes for TAVI with self-expanding or balloon-expandable valves according to physician discretion

Two-year findings of a post-hoc study from the GALILEO trial, investigating the clinical outcome...

PCR London Valves: First clinical data backs use of Jenavalve TAVI system in patients with aortic regurgitation

First clinical results of transcatheter aortic valve implantation (TAVI) using the Jenavalve sys...

PCR London Valves hears first results from NeoChord Nexus mitral repair device

The first 30-day results following the implantation of the NeoChord NeXuS transcatheter system f...

First 20 patients treated in first-in-man study of SavvyWire TAVI guidewire

Opsens has announced the successful treatment of 20 patients leading to the completion of the first ...

First patients enrolled in FAST III study of vFFR-guided PCI

The first patients have been enrolled in the FAST III trial at the Erasmus University Medical Center...

ESC publishes pandemic guidance on diagnosis and management of cardiovascular disease

European Society of Cardiology (ESC) guidance for the diagnosis and management of cardiovascular dis...

SCAI pushes revised standardised language to improve cardiogenic shock care

New guidance on the diagnosis and presentation of cardiogenic shock aims to simplify and standar...

Findings of meta-analysis “move the conversation forward” on left main revascularisation

A meta-analysis comparing percutaneous coronary intervention (PCI) using a drug-eluting stent (D...

AHA 2021: Updated risk score aims to predict contrast-associated kidney injury after PCI

An updated risk score to predict possible contrast-associated acute kidney injury (CA-AKI) among...

AHA 2021: VEST device may lead to increased saphenous vein graft longevity after CABG

Use of a novel, venous external support device (VEST, Vascular Graft Solutions) may lead to incr...

HeartVista receives FDA clearance for use of its AI software on Siemens MRI scanners

HeartVista has received US Food and Drug Administration (FDA) 510(k) clearance to deliver its AI-ass...

AHA 2021: RAPID CABG trial finds in favour of bypass surgery sooner after ticagrelor cessation

Coronary artery bypass graft sugery (CABG) between two and three days after ticagrelor cessation was...

AHA 2021: Asymptomatic AS patients benefit from early valve replacement surgery

Asymptomatic patients with severe aortic stenosis (AS) may benefit from early aortic valve replaceme...

What to expect from AHA 2021

Ahead of the American Heart Association’s 2021 annual scientific sessions (AHA 2021, 13–15 November,...

ADVERTORIAL Chronic total occlusion: The last frontier in the cath lab

This advertorial is sponsored by iVascular Treatment of a chronic total occlusion (CTO)—a complet...

“Promising” early data shared on alternatives to paclitaxel DCBs at TCT 2021

Early data presented at the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021; ...

Abbott research highlights opportunities for improvements in diagnosis and treatment of cardiovascular disease

Abbott has released new research from its Beyond Intervention initiative, a multi-year global resear...

Ron Waksman joins SIS Medical AG advisory board

SIS Medical AG has appointed Ron Waksman, associate director Division of Cardiology, MedStar Was...

Lessons from SURTAVI

Transcatheter aortic valve implantation (TAVI) pioneer and principal investigator of the SURTAVI tri...

Cardiovascular Systems announces enrolment in first-in-human study of everolimus-coated coronary DCB

Cardiovascular Systems has announced the start of enrolment in a first in-human trial of the coronar...

Patients more likely to survive a cardiac arrest in the operating room than the cath lab

Patients who went into cardiac arrest in the cardiac cath lab were more likely to survive to hospita...

Two-year results of mitral valve repair using ChordArt device published

CoreMedic has announced the publication of two-year follow-up results from the first in-human CHAGAL...

Medtronic announces 2045 net zero emissions ambition to combat climate change

Medtronic has announced its ambition to achieve net zero carbon emissions by fiscal year 2045 across...

TCT 2021: BIOSOLVE-IV data offer reassurance over rates of scaffold thrombosis from Magmaris bioresorbable scaffold

Data from the BIOSOLVE-IV trial, presented at the Transcatheter Cardiovascular Therapeutics annu...

TCT 2021: Six-month TRISCEND results “encouraging” for Evoque tricuspid valve

Six-month results from the TRISCEND study of the Evoque (Edwards Lifesciences) transcatheter tri...

TCT 2021: Early data presented for Intrepid TMVR using transfemoral delivery system

Early data for the self-expanding Intrepid (Medtronic) transcatheter mitral valve replacement (T...

TCT 2021: SWISS-APERO trial finds lower rate of peri-device leak in Amulet compared to Watchman FLX LAAC device

Findings of the SWISS-APERO trial, presented at the Transcatheter Cardiovascular Therapeutics an...

TCT 2021: Endoscopy study could have implications for post-PCI antiplatelet regimens

Patients receiving antiplatelet therapy following percutaneous coronary intervention (PCI) devel...

TCT 2021: Studies show improved outcomes for high-risk PCI patients using Impella

The final results of the PROTECT III and Restore EF prospective studies demonstrate improved out...

TCT 2021: LAAC remains non-inferior to NOAC for cardiovascular events at long-term follow-up

Left atrial appendage occlusion (LAAC) remains non-inferior to non vitamin-K-antagonists (NOACs)...

TCT 2021: Five-year SURTAVI data show comparable performance for TAVI and SAVR on mortality, stroke

Five-year clinical and echocardiographic outcome data from the SURTAVI randomised trial comparin...

TCT 2021: CHOICE-CLOSURE finds higher rate of access-related vascular complications in plug-based closure strategy post-TAVI

Results from the largest randomised trial to date comparing different closure device strategies ...

TCT 2021: TAVI in low-risk patients is cost effective, PARTNER 3 finds

An economic analysis of data from the PARTNER 3 randomised trial, comparing transcatheter aortic...

TCT 2021: CHEETAH study demonstrates safety of continuous aspiration to remove blood clots in the heart

Penumbra has announced that the CHEETAH clinical study of its Indigo system CAT RX catheter succ...

TCT 2021: “Sustained benefit” in patients undergoing IVL prior to coronary stenting

One-year outcomes from the Disrupt CAD III clinical study of Shockwave intravascular lithotripsy (IV...

TCT 2021: Patients with diabetes undergoing PCI have less target lesion failure with amphilimus-eluting stents

Results from SUGAR, a randomised controlled, multicentre trial conducted exclusively in patients wit...

TCT 2021: Randomised trials show “consistent” reduction in blood pressure through renal denervation

Randomised placebo-controlled trials show consistently that renal denervation provides significant r...

TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal denervation

Six-month outcomes from the randomised RADIANCE-HTN TRIO trial, comparing endovascular ultrasoun...

TCT 2021: QFR-guided lesion selection improves PCI outcomes in FAVOR III trial

Lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed phys...

TCT 2021: CABG “remains the treatment of choice” for complex, three-vessel coronary artery disease

Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) did not meet no...

Cardiovascular News 63 – November 2021: US Edition

In this issue:  MASTER DAPT game changing for short-duration dual antiplatelet therapy (DAPT) ...

Cardiovascular News 63 – November 2021: OUS Edition

In this issue:  MASTER DAPT game changing for short-duration dual antiplatelet therapy (DAPT) ...

TCT 2021: Philips to showcase developments in its interventional portfolio

Royal Philips has previewed updates in its product portfolio and new data due to be shared at the Tr...

Procyrion’s Aortix percutaneous mechanical circulatory support device features at TCT 2021

Procyrion has announced the presentation of studies at the Transcatheter Cardiovascular Therapeutics...

Aktiia announces Series A funding round

Hypertension health-tech firm Aktiia has announced a US$17.5 million Series A round of funding t...

ReValve Solutions announces first use of its Palmetto mitral valve replacement system

ReValve Solutions has announced that it has successfully completed the first-in-human use of its tra...

TCT 2021: Studies to highlight patient outcomes with Impella

Results from two studies of the Impella heart pump device will be presented at the Transcatheter Car...

Bifurcation lesions: Exploring the latest science

This educational supplement, sponsored by Medtronic, explores the latest evidence covering the treat...

AHA and ACC release clinical guidelines for evaluation of chest pain

Joint clinical practice guidelines have been issued by the American Heart Association (AHA) and the ...

EACTS speakers question evidence underpinning guidelines for left main revascularisation

Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACTS 2021; 13–16 Octobe...

Longest available real-world follow-up data for Tendyne valve support use of device in select patients

The longest available real-world follow-up data of transcatheter mitral valve implantation (...

Enrolment completed in study of Teleflex QuikClot device

Teleflex announced the completion of patient enrolment in a clinical study evaluating the performanc...

Research finds poor level of surveillance following aortic dissection repair

Patients who survive an aortic dissection often fail to receive ​​comprehensive post-surgical fo...

CRF waives cost for digital access to TCT 2021

The Cardiovascular Research Foundation (CRF) has announced that the digital component of the Transca...

PIONEER III trial results demonstrate safety and efficacy of HT Supreme stent

Sinomed has announced that the PIONEER III clinical trial results for its HT Supreme drug-elutin...

Cardiac CTA parameters predict post-TAVI mortality

Cardiac CT angiography (CTA) derived left atrium emptying fraction (LAEF) improves predictive pe...

First European implants of Trilogy TAVI system completed

JenaValve Technology has announced the first commercial implants with the Trilogy heart valve System...

Heartflow announces start of REVEALPLAQUE clinical trial

HeartFlow has announced the commencement of the REVEALPLAQUE trial to evaluate the company’s non-inv...

Study charts “inequities” in growth of TAVI in US hospitals

The expansion of transcatheter aortic valve implantation (TAVI) in the USA has predominantly centred...

Ethnic and racial minority cardiologists face professional discrimination and exclusion

Ethnic and racial minority cardiologists report career satisfaction but face professional discrimina...

EACTS 2021: Panel urges action over lack of representation of women in coronary revascularisation trials

The underrepresentation of women in clinical coronary revascularisation trials may encourage tre...

Clinical study of SavvyWire TAVI guidewire commences

OpSens has announced the commencement of the human clinical study utilising the SavvyWire, and succe...

Next generation of aortic surgeons need open and endovascular skills

Building and maintaining expertise in both open and endovascular surgical techniques will play a...

ReCor Medical’s Paradise ultrasound renal denervation system used in first German cases

ReCor Medical has announced that its Paradise ultrasound renal denervation system is now available f...

Baylis Medical Company to sell its cardiology business to Boston Scientific

Baylis Medical Company has reached an agreement to sell its cardiology business to Boston Scientific...

Philips’ Bert van Meurs discusses the future of imaging in the cath lab

Bert van Meurs is the chief business leader for Image Guided Therapy within Royal Philips, the multi...

NeoChord announces completion of first-in-human case with NeXus TMVr technology

NeoChord has announced successful completion of the first-in-human procedure with the NeoChord NeXuS...

Cardiovascular News’ top 10 most popular stories of September 2021

Top stories for September included more highlights from the European Society of Cardiology’s 2021 co...

Lankenau Heart Institute and Philips announced integrated cardiovascular solutions partnership

Royal Philips and Lankenau Heart Institute part of Main Line Health (Wynnewood, USA) have announced ...

FDA monitoring gender differences in outcomes with LAAO devices

The US Food and Drug Administration (FDA) has informed healthcare providers of recent information ab...

Enrolment completed in study of Tria aortic valve

Tria
Foldax has announced completion of enrolment in the US early feasibility study of the Tria surgical ...

Siemens launches Luminos Impulse fluoroscopy system

Siemens Healthineers has launched the Luminos Impulse fluoroscopy system, including features such as...

Abbott’s Amplatzer Talisman gains FDA approval

Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's Ampla...

Biotronik gains FDA approval for the Orsiro Mission drug-eluting stent

Orsiro Mission DES
Biotronik has announced that it has received US Food and Drug Administration (FDA) approval of i...

Waiting list mortality for coronary procedures exacerbated during pandemic

Patients awaiting coronary artery bypass grafting (CABG) or percutaneous coronary intervention (...

Open Stent Solution closes €2.5 funding round

Open Stent Solution (OSS) has announced the closing of a €2.5 million Seed financing round. The fund...

HRX digital health event moved to September 2022

The Heart Rhythm Society (HRS) has announced that its cardiovascular digital health conference—HRX—h...

Cardiac, vascular and endovascular leaders convene for CX Aortic Vienna

CX Aortic Vienna
Capturing the latest developments in the comprehensive treatment of aortic disease—from the aortic v...

ADVERTORIAL: Optimising TAVI device choice

This advertorial is sponsored by Medtronic As transcatheter aortic valve implantation (TAVI) ...

Neovasc to begin COSIRA-II trial of Reducer for refractory angina

Neovasc has announced that it has received Food and Drug Administration (FDA) approval for the inves...

FDA approves Abbott’s Epic Plus tissue valves for mitral and aortic valve replacement

Abbott has announced that the US Food and Drug Administration (FDA) has approved the company’s Epic ...

Registry data show comparable outcomes for bicuspid and tricuspid TAVI in low-risk patients

Patients at low surgical risk who had undergone transcatheter aortic valve implantation (TAVI) f...

Surgical team completes first implant of Aeson bioprosthetic heart in a female patient

A cardiothoracic surgical team with UofL Health–Jewish Hospital and the University of Louisville...

Ultrasound guidance “should be routine” for transfemoral TAVI access

Ultrasound-guided transfemoral transcatheter aortic valve implantation (TAVI) is associated with...

Randomised trials needed to evaluate safety and efficacy of TMVR

Randomised trials are needed to evaluate the safety and effectiveness of transcatheter mitral va...

Abbott receives FDA approval for Portico with FlexNav TAVI system

Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's P...

OpSens receives Health Canada approval to begin clinical study of TAVI guidewire

OpSens has announced that it has received Health Canada approval to commence the first in-man study ...

Renal denervation: The most advanced and efficacious interventional approach to treat hypertension

Following the release of the European Society of Hypertension’s (ESH’s) updated position paper o...

Long-term preclinical results of Xeltis’ restorative CABG graft presented at ISACB 2021

One-year data from preclinical trials of Xeltis restorative coronary artery bypass graft (XABG) show...

TCT 2021: Late-breaking trials programme announced

The Cardiovascular Research Foundation (CRF) has announced 22 late-breaking trial and science pr...

ESH position paper highlights renal denervation as a third option for hypertension management

European Society of Hypertension (ESH), the leading hypertension (HTN) society in Europe, presented ...

Peijia Medical announces first implant in the clinical trial of its TaurusNXT TAVI system

Peijia Medical has announced the initiation of its multicentre clinical trial for TaurusNXT, the...

Christoph Naber

Christoph Naber (Essen, Germany) talks to Cardiovascular News about his career in interventional car...

New imaging technique has the potential to identify patients at high risk of aortic degeneration

Four-dimensional (4D) flow magnetic resonance imaging (MRI) has the potential to identify patien...

CytoSorbents files IDE for clinical trial of DrugSorb-ATR used during cardiothoracic surgery

CytoSorbents has filed an investigational device exemption (IDE) application to gain US Food and Dru...

STENTiT makes trio of appointment to its medical advisory board

STENTiT, a medical device company bringing a novel class of regenerative endovascular implants f...

No-touch CABG technique “reduces risk of vein graft occlusion” after 12 months

When a modified surgical technique was used to gently remove sections of leg veins used in coronary ...

ABILITY Diabetes Global enrols thousandth patient

Concept Medical has announced the enrolment of the thousandth patient in ABILITY Diabetes Global (Ra...

Digital app speeds up time to STEMI care

“During a heart attack time is myocardium,” says Annapoorna Kini (New York, USA) discussing the ...

Cannabis use in younger adults linked to increased risk of myocardial infarction

Adults younger than 45 years who reported recently using cannabis were two times more likely to have...

Cardiovascular News’ top 10 most popular stories of August 2021

August’s top 10 features a stark warning over representation of women in clinical trials relating to...

HeartFlow announces enrolment of first three patients in FUSION trial

HeartFlow has announced that physicians at Erasmus MC Hospital (Rotterdam, The Netherlands) have...

ESC 2021: STOPDAPT-2 ACS does not support clopidogrel monotherapy one-month after ACS

Findings of the STOPDAPT-2 ACS trial presented during a hot line session at the European Society...

ESC 2021: Abbott’s Amulet occluder shows promise against Watchman device in AF treatment

Abbott has announced late-breaking data from the Amulet LAA Occluder IDE trial, a multicentre, h...

ESC 2021: Drones touted as the future of defibrillator delivery

The world’s first feasibility study has found that drones can be used to deliver defibrillators to p...

ESC 2021: New guidelines for the diagnosis and treatment of acute heart failure published

The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chr...

ESC 2021: Study charts impact of following health advice after a heart attack

Adherence to lifestyle advice and medications could add seven healthy years of life after a heart at...

Second hospital implants Aeson bioprosthetic artificial heart

CARMAT has announced the second centre implanting its bioprosthetic artificial heart, Aeson, in the ...

Medtronic gains FDA approval for its latest-generation TAVI system

Medtronic has announced US Food and Drug Administration (FDA) approval of its newest-generation, sel...

ESC 2021: Family history outweighed by lifestyle choices in study of premature heart attacks

Young heart attack victims are more likely to be smokers, obese, and have high blood pressure or...

EMPOWER trial to study Carillon mitral contour system

Cardiac Dimensions has announced the launch of the US pivotal study the EMPOWER trial, evaluatin...

Urgent TAVI patients more likely to be readmitted than elective cases

Readmissions within 30 days are more common following urgent, rather than elective, transcathete...

Cardiovascular News 62 – August 2021: OUS Edition

In this issue: Meta analysis draws out debate on coronary revascularisation What to expect w...

Cardiovascular News 62 – August 2021: US Edition

In this issue: Meta analysis draws out debate on coronary revascularisation What to expect w...

Ten-year outcomes of Yukon DES in diabetic patients published in JAHA

Translumina has announced the publication of 10-year clinical outcome data for its Yukon drug-elutin...

Ultromics completes US$33 million Series B funding round

Ultromics, a developer of AI enabled cardiovascular imaging solutions, has announced that it has rai...

FDA grants breakthrough device designation to Impella ECP

The US Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed...

Algorithm predicts heart failure hospitalisations

AI
Biotronik has announced the results from a new study published in EP Europace this week confirming t...

Sinomed announces the first commercial implantation and European launch of the HT Supreme DES

Sinomed has announced the first commercial implantation of the HT Supreme drug-eluting stent (DE...

App launched to cut time to treatment for STEMI patients

Physicians at Mount Sinai Health System (New York, USA) have developed a mobile application to exped...

Second US FDA breakthrough device designation granted to CytoSorbents’ DrugSorb-ATR

CytoSorbents has been granted a second breakthrough device designation for its DrugSorb-ATR antithro...

Abbott’s Amplatzer Amulet gains US FDA approval

Abbott has announced that the US Food and Drug Administration (FDA)  has approved the company's ...

Occlutech gains IDE approval for OCCLUFLEX pivotal study

Occlutech Holding has announced the conditional US Food and Drug Administration (FDA) approval of it...

“Virtual contrast agent” could offer benefit in cardiac MRI assessment

An imaging technology developed using artificial intelligence (AI) could become an alternative for l...

Caption Health gains NTAP authorisation from CMS for AI-guided ultrasound platform

Caption Health has announced that the Centers for Medicare and Medicaid Services (CMS) have appr...

Women underrepresented in cardiovascular clinical trials

Women remain underrepresented in cardiovascular clinical trials despite initiatives to ensure broade...

Realview Imaging gains FDA approval for Holoscope-i system

RealView Imaging has announced that it has received US Food and Drug Administration (FDA) 510(k) cle...

Back in the room: A welcome return to in-person education

With the COVID-19 pandemic having switched virtually all of the major meeting in the cardiovascu...

Cardiovascular News’ top 10 most popular stories of July 2021

Our top 10 stories of July 2021, including: A milestone for coronary balloon angioplasty; highlights...

Analysis reports “dramatic” drop in cardiac surgery procedures during COVID-19

The largest analysis of its kind to look at the impact of COVID-19 on adult cardiac surgery volu...

US launch for Abbott’s Ultreon AI-based coronary imaging platform

Abbott has announced that it has received US Food and Drug Administration (FDA) clearance for its la...

Edwards’ Konect Resilia and Mitris Resilia gain Health Canada approval

Edwards Lifesciences has announced that it has received regulatory approval from Health Canada for b...

PCI procedures drop by 10% in USA since 2010, research suggests

The USA saw a 10% decline in percutaneous coronary intervention (PCI) procedures between 2010 an...

AngelMed launches its Guardian device in the USA

Angel Medical Systems (AngelMed) has announced the first commercial implantation and US launch of it...

TVT 2021: MitraClip reduces hospitalisation in patients with secondary MR and heart failure

An analysis of the rates rehospitalisation and mortality in heart failure patients with secondar...

Medtronic launches Prevail DCB in Europe

Medtronic has announced the launch of the Prevail drug coated balloon (DCB) catheter in Europe follo...

ADVERTORIAL: DCB pioneer welcomes deliverability after first case with Medtronic’s brand new Prevail™ coronary DCB

This advertorial is sponsored by Medtronic The first case using the Prevail (Medtronic) pacli...

CathWorks FFRangio system receives reimbursement approval in Japan

CathWorks has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has appr...

TVT 2021: Aborted TEER leads to poorer outcomes in mitral valve surgery

Among patients undergoing mitral valve surgery after failed transcatheter edge-to-edge mitral va...

TVT 2021: 3M study suggests minimalist TAVI is safe, leads to “substantial” cost savings

Clinical and economic results from the 3M TAVR economic study have been presented at TVT 2021 (T...

TVT 2021: Outcomes in low-risk bicuspid and tricuspid TAVI patients similar at one year

Patients with bicuspid aortic stenosis may benefit as much from transcatheter aortic valve impla...

TVT 2021: Two-year PINNACLE FLX results report low rate of ischaemic stroke for Watchman FLX

Two-year results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-...

MedAlliance launches Origin balloons for vessel preparation

MedAlliance has launched Origin SC and Origin NC, two high performance balloons for vessel preparati...

Ancora Heart secures US$80 million in financing

Ancora Heart has closed US$80 million in equity financing, with the funds to be used to accelera...

HeartFlow announces merger agreement

HeartFlow has entered into a definitive business combination agreement with Longview Acquisition...

First Aeson bioprosthetic artificial heart implanted in USA

Carmat has announced the first implantation of its bioprosthetic artificial heart, Aeson, in the USA...

Pacemaker implantation after SAVR points to increased mortality and heart failure hospitalisation

Patients undergoing permanent pacemaker implantation after surgical aortic valve replacement (SA...

First patients treated with reSept ASD occluder in IDE trial

atHeart Medical has announced the successful treatment of the first five patients in its ASCENT ...

FDA approval for SafeCross transseptal RF system

East End Medical has announced it has received US Food and Drug Administration (FDA) clearance f...

Cardiovascular societies demand action to combat physician burnout

Global action is needed to improve clinician wellbeing, according to four leading cardiovascular hea...

Xeltis initiates synthetic restorative pulmonary heart valve pivotal trial

Xeltis has announced that it has started a pivotal trial for a synthetic restorative pulmonary valve...

Common cath lab practices under the microscope in AHA review

The American Heart Association (AHA) has published a scientific statement challenging “tradition...

Cardiovascular News’ top 10 most popular stories of June 2021

Our top 10 stories of June 2021, including: Analysis of the data for transcatheter aortic valve impl...

CytoSorbents gains IDE for STAR-T trial to remove ticagrelor during cardiothoracic surgery

CytoSorbents has received approval for its investigational device exemption (IDE) application to con...

Carta Healthcare’s AI software certified for use in CathPCI Registry

virtual stroke care
Carta Healthcare has announced that it has been certified as a National Cardiovascular Data Registry...

Sinomed partners with NUI Galway for HT Supreme stent trial

Sinomed has announced a partnership with the National University of Ireland Galway (NUI Galway, ...

More experienced TAVI centres “less likely to use heart team approach”

Assessment of patients by both interventional cardiologists and cardiac surgeons prior to transc...

First patient treated with VeriSight Pro 3D intracardiac echocardiography catheter

Royal Philips has announced the first procedure using its real-time 3D intracardiac echocardiography...

Xience stent receives US FDA approval for short-duration DAPT

Abbott has today announced that its Xience family of stents has received US Food and Drug Admini...

Cardiothoracic surgery guidelines updated to optimise blood management among cardiac patients

Clinical practice guidance released today outline recommendations for reducing blood loss during...

Electroducer raises funding to market its external pacemaker device

Electroducer has announced that it has raised €3 million (US$3.65M) from private investors and Frenc...

Vaccine myocarditis risk “far outweighed” by COVID-19 infection

The risk of heart damage from COVID-19 infection is far greater than that from receiving a dose of t...

Pandemic contributes to worsening heart attack outcomes, study finds

Heart attacks during the COVID-19 pandemic were more likely to result in heart failure compared ...

AngelMed gains FDA approval for enhanced real-time cardiac monitor for ACS events

Angel Medical Systems (AngelMed) has announced US Food and Drug Administration (FDA) approval of the...

One in eight CABG patients readmitted within 30 days, meta-analysis finds

Nearly one in eight coronary artery bypass graft (CABG) patients are readmitted within 30 days o...

Medtronic Canada completes end-to-end remotely-guided TAVI procedure

The first end-to-end remotely guided transcatheter aortic valve implantation (TAVI) procedure us...

Tendyne receives breakthrough designation for MAC patients

Abbott has received Breakthrough Device designation from the US Food and Drug Administration (FD...

Royal Philips announces start of DEFINE GPS study

Philips iFR Coregistration SyncVision
Royal Philips has announced the official start of the DEFINE GPS study, with the first patient b...

Registry DAPT data “could support clinical trials”

Data captured in the National Cardiovascular Data Registry (NCDR) is similar in quality, depth a...

Long-term study finds QoL improvements in CABG patients despite complications

An investigation into the impact of postoperative complications on long-term quality of life (QoL) a...

Cindy Grines

Cindy Grines is an interventional cardiologist and chief scientific officer of Northside Hospital Ca...

PCI complexity does not influence efficacy of ticagrelor or prasugrel in acute coronary syndrome patients

In patients with acute coronary syndrome treated with percutaneous coronary intervention (PCI), ...

“Rapid increase” in cardiovascular disease-related deaths in Asia

The number of people dying from cardiovascular disease (CVD) in Asia is increasing rapidly, with ove...

Study of CorWave’s LVAD presented at ASAIO annual meeting

CorWave has announced that it has successfully completed the first 90-day preclinical study to evalu...

Circulation publishes special edition dedicated to disparities in cardiovascular medicine

Circulation the flagship journal of the American Heart Association (AHA) has published online its fi...

Shockwave’s coronary IVL device gains TPT payment approval

Shockwave Medical has announced today that the Centers for Medicare & Medicaid Services (CMS) ha...

Delaying CABG after AMI may not improve outcomes

A study looking at the timing of coronary artery bypass grafting (CABG) after the occurrence of acut...

Caution needed for TAVI in younger, low-risk aortic stenosis patients

Pivotal trials of transcatheter aortic valve implantation (TAVI) in low-risk patients have, so f...

Neurescue’s aortic occlusion device gains US FDA approval

Neurescue has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance ...

Pulmonary artery proportional pulse pressure monitoring could improve survival for heart failure patients

A new physiological measurement of heart function could improve survival for people with heart f...

TRISCEND study demonstrates significant reduction in TR with Evoque tricuspid valve

Early experience with the Evoque (Edwards Lifesciences) tricuspid valve replacement system demonstra...

GE Healthcare and ACC partner to advance AI in cardiology

GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and ...

Medtronic stops sale of its HVAD system

Medtronic is stopping the distribution and sale of the Medtronic HVAD system. This morning, the ...

Targeted healing: A new stent concept that could contribute to shortened DAPT

This advertorial is sponsored by Sinomed As newer-generation drug-eluting stent (DES) technol...

Cardiovascular News’ top 10 most popular stories of May 2021

Our top 10 stories of May 2021, including highlights from both EuroPCR 2021 (18–20 May, virtual), an...

Physician gender does not impact outcomes in PCI patients

There does not appear to be a relationship between operator and patient gender and outcome in patien...

Siemens Healthineers receives CE mark for the ACUSON AcuNav Volume ICE catheter

Siemens Healthineers has announced that it has received CE Mark for the AcuNav Volume ICE (intracard...

LivaNova completes initial divestiture of its heart valve business

LivaNova has successfully completed the initial closing of the divestiture of its heart valve bu...

Female aortic dissection patients presenting later, have higher mortality

Women who experience acute aortic dissection are older, have more advanced disease than men when...

Abiomed acquires breakthrough device company preCARDIA

Abiomed has acquired preCARDIA, developer of a proprietary catheter and controller to expand options...

Sinomed announces presentation of PIONEER III data at EuroPCR 2021

Sinomed has announced results from the HT Supreme healing-targeted drug-eluting stent (DES), in ...

Patients at high risk of bleeding—A forgotten population in PCI?

There is an increasing understanding of the need for tailored strategies when treating  high-bleedin...

COVID-19 puts a spotlight on the need for investment in resources for cardiac surgery

A call for greater investment in surgical facilities in the UK in the wake of the COVID-19 pandemic ...

EuroPCR 2021: Interventional cardiologists sound the alarm over silent impact of the pandemic

Interventional cardiologists from across the globe are joining forces for a campaign reinforcing...

Intravascular lithotripsy: Not an eccentric option for eccentric calcium

This advertorial is sponsored by Shockwave Medical. Severe coronary artery calcification presents...

MDR comes into effect across EU

The European Union (EU) Medical Devices Regulation (MDR) takes effect from today (26 May 2021). T...

First-in-human use of Tria biopolymer heart valve completed

Tria
Foldax has announced the successful first-in-human use of its biopolymer Tria heart valve in surgica...

First patients treated with Aortix pMCS device

complete-revascularisation
Procyrion has announced the treatment of the first patients in the pilot trial to evaluate the perfo...

EuroPCR 2021: Image-guided PCI study demonstrates non-inferiority of ultra-thin stent

Investigation of the use of an ultra-thin strut biopolymer sirolimus-eluting (BP-SES; Orsiro, Bi...

RE-ACCESS study has implications for TAVI valve selection

This advertorial is sponsored by Boston Scientific In recent years, transcatheter aortic valv...

TricValve transcatheter bicaval valve system receives CE mark

OrbusNeich and P&F Products & Features, under the joint partnership OrbusNeich P&F, have...

EuroPCR 2021: Study details dual mechanism of Diamondback orbital atherectomy system

Results of an observational study using optical coherence tomography (OCT) to assess the efficac...

EuroPCR 2021: FUTURE-II hints at promise for Firesorb bioresorbable scaffold

One-year results of the FUTURE-II study—a randomised trial comparing a thin-strut bioresorbable ...

EuroPCR 2021: Meta-analysis supports elective coronary revascularisation

A meta-analysis of randomised trials comparing a strategy of revascularisation plus medical therapy ...

ACC.21: Clopidogrel monotherapy trumps aspirin for long-term maintenance after PCI

Clopidogrel monotherapy produced better outcomes than aspirin for the long-term maintenance of p...

EuroPCR 2021: 10-year DISCOVER-FLOW results back HeartFlow FFRct analysis

HeartFlow has announced new data which indicate that the information provided by the HeartFlow F...

ACC.21: VOYAGER PAD analysis shows reduced risk of ischaemic events in PAD patients receiving rivaroxaban

Rivaroxaban (Xarelto, Bayer/Janssen), in addition to low-dose aspirin, should be considered as a...

EuroPCR 2021: Two-year results of Evolut Low Risk trial “reassuring” for TAVI in low-risk patients

Complete two-year follow-up data from the Evolut Low Risk trial, presented during a late-breakin...

EuroPCR 2021: Biotronik touts two-year data from BIOSOLVE-IV registry

Long-term follow-up data from the BIOSOLVE-IV registry, presented at the EuroPCR 2021 meeting (1...

FAST II underscores vFFR as a “faster and easier” physiological lesion assessment tool

This advertorial is sponsored by PIE Medical Findings of the multicentre FAST II clinical tri...

EuroPCR 2021: Registry data show low rates of PVL and PPI for Acurate neo2

Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress (18–20 M...

EuroPCR 2021: Philips shares cardiac imaging and software developments

Royal Philips has announced the European availability of new innovations in its portfolio of solutio...

ZOLL Medical receives FDA IDE approval for ISO Shock study

ZOLL Medical Corporation has announced that the US Food and Drug Administration (FDA) has approv...

Abbott’s Navitor TAVI system receives CE mark

Abbott has announced it has received CE mark for its latest-generation transcatheter aortic valve im...

ACC.21: High-sensitivity troponin T-test protocol did not improve outcomes in suspected ACS patients

Among patients with suspected acute coronary syndrome (ACS), the use of a high-sensitivity tropo...

ACC.21: Pandemic has seen burnout “double” among cardiology professionals

The proportion of cardiologists reporting burnout has nearly doubled during the COVID-19 pandemi...

ACC.21: FLOWER-MI finds no benefit to FFR-guided PCI in STEMI patients with multi-vessel disease

ST-elevation Myocardial Infarction (STEMI) patients with multi-vessel disease undergoing percuta...

ACC.21: DAPT de-escalation may benefit AMI patients

Switching from ticagrelor to clopidogrel dual antiplatelet therapy (DAPT) after 30 days was safe...

ACC.21: Registry data show low rate of stroke at one year following LAAO with Watchman

Transcatheter left atrial appendage occlusion (LAAO) with a Watchman (Boston Scientific) device ...

ACC.21: Apixaban not superior to standard of care following TAVI

Apixaban was not superior to standard of care following transcatheter aortic valve implantation ...

ACC.21: LAAO after heart surgery offers “new paradigm” for stroke prevention in AF patients

Patients with an elevated risk of stroke due to arrhythmia or atrial fibrillation (AF), were much le...

COBRA PzF stent demonstrates long-term safety at five years post-PCI

CeloNova BioSciences that its COBRA PzF nanocoated coronary stent (NCS) achieved exceptional lon...

Philips adds haemodynamic measurement to Azurion image-guided platform

Royal Philips has announced the integration of its Interventional Hemodynamic system and portable pa...

Leaflex: Changing the conversation around aortic stenosis?

This advertorial is sponsored by Pi-Cardia As more transcatheter aortic valve implantation (TAVI)...

Preventing kidney damage in the cath lab

This advertorial is sponsored by Osprey Medical There is a growing recognition of the risk of con...

Hostile environment: Cardiologists report high prevalence of discrimination and harassment in the workplace

Discrimination and harassment are a common experience among those working in cardiology, according t...

Cardiovascular News 61 – May 2021: OUS Edition

In this issue: Hostile environment: How cardiologists feel about discrimination in the workplac...

Cardiovascular News 61 – May 2021: US Edition

In this issue: Hostile environment: How cardiologists feel about discrimination in the wo...

Study shows increasing diversity among US cardiothoracic surgery residents

Research presented at the American Association for Thoracic Surgery 101st Annual Meeting (AATS 2021,...

ACC.21: Digital app should replace stent cards as a patient PCI record

Fewer than half (48%) of patients undergoing percutaneous coronary intervention (PCI) still had ...

Cardiology trainees require preparation to adapt to shift towards telemedicine

A significant proportion of cardiology trainees are uncomfortable with using telemedicine and fe...

AGENT IDE trial to evaluate DCB-use in patients with coronary in-stent restenosis

Boston Scientific has announced it has initiated the AGENT IDE trial for the Agent drug-coated ballo...

Mild COVID-19 unlikely to lead to lasting heart damage

Mild COVID-19 infection is unlikely to cause lasting damage to the structure or function of the hear...

Abbott initiates trial focusing on twin AF and heart failure treatments

Abbott has announced a new trial focused on improving the treatment for people simultaneously battli...

Cardiovascular News’ top 10 most popular stories of April 2021

Our top 10 stories of April 2021, including: highlights from the Society for Cardiovascular Angiogra...

ACC.21: App speeds up time to PCI for STEMI patients

ST-elevation myocardial infarction (STEMI) patients received percutaneous coronary intervention (PCI...

SCAI names Timothy Henry as president

Timothy D Henry (The Christ Hospital Medical, Cincinnati, USA) has assumed the office of preside...

Mitral regurgitation patients treated with TEER will require mitral replacement surgery if treatment fails

Patients suffering from severe mitral regurgitation should be carefully screened and counselled befo...

Medtronic’s Evolut PRO+ TAVI system gains CE mark

Medtronic has announced that it has received the CE mark for the Evolut PRO+ transcatheter aorti...

SCAI 2021: ISCHEMIA trial population not reflected in real-world patients

Patients studied in the ISCHEMIA trial, the largest trial to date to compare revascularisation w...

SCAI 2021: Robotic PCI achieves high clinical and technical success “in a wide spectrum of lesions”

Robotic-assisted percutaneous coronary intervention (PCI) using the second-generation CorPath GR...

SCAI 2021: Prolonged DAPT “should remain the standard of care” in ACS patients

Analysis of the prospective Fuwai PCI Registry using selection criteria from the TWILIGHT trial, has...

SCAI updates consensus guidelines on cath lab standards

The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus...

SCAI 2021: Research lays bare the impact of the COVID-19 pandemic on STEMI care

Two research papers presented at the Society for Cardiovascular Angiography and Interventions vi...

SCAI 2021: Interim OPTIMIZE PRO results point to benefit for cusp overlap TAVI technique

Medtronic has announced results from an interim analysis of the first 171 patients (including 71...

Hospitalised COVID-19 patients at risk of developing heart failure

Patients hospitalised with COVID-19 may be at risk of developing heart failure even if they do n...

CE mark for BACE device for functional mitral regurgitation

Phoenix Cardiac Devices has announced that it has received CE mark for its Basal Annuloplasty of the...

CytoSorbents granted US FDA approval for STAR-T trial

CytoSorbents has announced that the US Food and Drug Administration (FDA) has granted conditional ap...

Societies publish initial findings of NACMI registry of STEMI patients with COVID-19

Initial findings from the North American Cardiovascular COVID-19 Myocardial Infarction (NACMI) R...

First patient enrolled in PROTECT IV randomised controlled trial of Impella

Abiomed has announced that the first patient has been enrolled in PROTECT IV, a large, prospecti...

Researchers create heart replicas from CT images

Researchers from King's College London (London, UK) have created 3D replicas of full-sized healthy a...

UK study suggests that COVID-19 patients are at elevated risk during cardiothoracic surgery

A retrospective observational study of patients undergoing cardiac surgery in the UK between March a...

Cardiothoracic surgeons mobilised for COVID-19 research

The work of the Cardiothoracic Surgical Trials Network (CTSN) in mobilising resources for COVID-19 r...

AcQCross transseptal crossing devices gain US FDA clearance

Acutus Medical has announced US Food and Drug Administration (FDA) clearance of the AcQCross family ...

First procedure performed in SMART head-to-head TAVI study

The first procedure has been completed in SMART (Small Annuli Randomized to Evolut or Sapien) po...

Next generation TriClip gains CE mark approval

Abbott has received CE mark for its next-generation TriClip transcatheter tricuspid valve repair sys...

Cardiovascular News’ top 10 most popular stories of March 2021

Our top 10 stories of March 2021, including: highlights from CRT 2021; converging TAVI and surgery o...

COVID-19 “lays the foundation for a digital shift in cardiovascular care”

More patients, particularly those with medical risk factors or from underserved communities, opt...

Understanding trends in TAVI and surgical aortic valve replacement

With recent data pointing to a shift towards more transcatheter aortic valve implantation (TAVI) pro...

Xience stent receives CE mark for short duration DAPT

Abbott has announced that its Xience stent has received CE mark in Europe for shorter duration o...

Dipti Itchhaporia begins term as ACC president

Dipti Itchhaporia has today begun her term as president of the American College of Cardiology (A...

Randomised trial data supports use of the PleuraFlow system

ClearFlow has announced clinical trial results published in the Journal of Cardiothoracic Surgery ev...

One in three female cardiologists report unwanted advances

More than a third of female cardiologists polled in a UK survey on discrimination and sexism in the ...

Older STEMI patients found to be more reluctant to undergo PCI in Chinese study

Patients aged over 65 years were more likely than their younger counterparts to turn down percutaneo...

How the LightLab initiative is examining the value of OCT in the cath lab

Matheen Khuddus (director of Cardiovascular Research, The Cardiac & Vascular Institute, Gainesvi...

B Braun and Infraredx collaborate on IDE clinical trial for the SeQuent Please ReX

B Braun Interventional Systems has announced a collaboration with Infraredx to accelerate the US Foo...

Alvimedica gains CE mark approval for Fluydo NC balloon catheter

Alvimedica has announced CE mark approval of Fluydo NC, its PTCA non-compliant balloon catheter. ...

Medtronic receives FDA approval for Harmony transcatheter pulmonary valve

Medtronic has received US Food and Drug Administration (FDA) approval for its Harmony transcatheter ...

Academic reputation does not determine following for interventional cardiology influencers

Social media has become an important platform for promoting research within the interventional cardi...

Cordella pulmonary artery pressure sensor reaches 100-implant milestone

Endotronix has announced the 100th global implant of the Cordella pulmonary artery pressure sens...

Viagra may prolong life for men with coronary artery disease

Men with stable coronary artery disease who receive Viagra due to impotence seem to live longer ...

Shockwave Medical to bring IVL to the Chinese market

Shockwave Medical has announced that the company has signed an agreement to form a joint venture wit...

Mavacamten granted US FDA new drug application

Bristol Myers Squibb has announced that the US Food and Drug Administration (FDA) has accepted its n...

Stephan Achenbach

Stephan Achenbach is professor of medicine at the University of Erlangen, Erlangen, Germany and pres...

CRT 2021: Three-year COMPARE ABSORB results show similar TLF rate between Absorb scaffold and Xience stent

Three-year results from the COMPARE-ABSORB trial, presented during a late-breaking trial session...

CRT 2021: Polymer-free amphilimus-eluting stent non-inferior to zotarolimus-eluting stent in PCI patients

Three-year clinical outcomes from the Recre8 trial, a multicentre study comparing the safety and eff...

Lab-grown heart valves capable of growth in recipient, research finds

Lab-created heart valves implanted in young lambs were capable of growth within the recipient, a...

Imbio receives FDA 510(k) clearance for cardiothoracic imaging algorithm

Imbio has received US Food and Drug Administration (FDA) 510(k) clearance for its RV/LV Analysis alg...

Cardiovascular Systems announces first uses of Wirion embolic protection system

Cardiovascular Systems has announced that the first patients in the USA have been treated with the W...

CytoSorbents files IDE for US trial on ticagrelor removal during cardiothoracic surgery

CytoSorbents has announced the filing of an investigational device exemption (IDE) application to co...

Elixir Medical commences INFINITY-SWEDEHEART randomised study of DynamX bioadaptor

Elixir Medical has today announced commencement of the INFINITY-SWEDEHEART randomised controlled tri...

CardioRisk: Addressing atherosclerotic risk factors among Egypt’s ACS patients

Ahmed Bendary (Benha University, Benha, Egypt) details the CardioRisk project, an initiative to ...

CRT 2021: BIOSTEMI shows superiority of Orsiro stent to Xience for target lesion failure at two years

Two-year follow-up data the BIOSTEMI trial, presented during a late-breaking trial session at th...

CRT 2021: One-year outcomes after TAVI in low-risk bicuspid aortic stenosis patients meet expectations

Clinical outcomes up to one year after transcatheter aortic valve implantation (TAVI) in low-ris...

Five-year results of Gore REDUCE clinical study published

Five-year follow-up results from the Gore REDUCE study, assessing the Gore Cardioform or Helex s...

ACC.21 late-breaking clinical trial programme announced

The American College of Cardiology (ACC) has announced a number of the late-breaking clinical trials...

CRT 2021: Registry data highlights growing use of DOACs among bioprosthetic heart valve patients

Registry data charting the use of direct oral anticoagulants (DOACs) in patients receiving mecha...

CRT 2021: Registry data finds BASILICA has a low coronary artery obstruction rate

Data from an international registry of patients undergoing a procedure known as BASILICA, which ...

Cardiovascular News’ top 10 most popular stories of February 2021

Our top 10 stories of February 2021, including: the relationship between TAVI volumes and outcomes; ...

Approval allows use of single access Impella procedure across Europe

Following consultation with its notified body, MEDCERT GmbH, Abiomed is introducing the single acces...

ControlRad Select imaging system gains FDA market clearance

ControlRad has announced US Food and Drug Administration (FDA) 510(k) clearance to market Contro...

Three-month DAPT after PCI with Synergy stent supported in EVOLVE Short DAPT trial

Favourable rates of ischaemic outcomes were observed among selected high bleeding risk patients ...

Societies collaborate to develop universal heart failure definition

A global collaboration between international heart failure bodies seeks to standardise the language ...

MedAlliance gains FDA breakthrough designation for sirolimus DEB treatment of de novo coronary lesions

MedAlliance has been awarded breakthrough status for Selution SLR, its sustained limus release drug-...

ICS announces first use of its Emblok system in Europe

Innovative Cardiovascular Solutions (ICS) has announced the success of its first European clinic...

FDA approval for Viola clampless proximal anastomosis device

Vascular Grafts Solutions has announced receipt of marketing clearance from the US Food and Drug Adm...

Two-year PARTNER 3 outcomes show convergence between TAVI and surgery on stroke and death

Two-year outcomes of the PARTNER 3 clinical trial, in which low surgical risk aortic stenosis pa...

CRT 2021: Analysis compares cangrelor favourably to glycoprotein IIB

An analysis of antiplatelet therapies used during percutaneous coronary intervention (PCI) has c...

Analysis shows proportionality fails to account for divergent COAPT and Mitra-FR trials

A secondary analysis of the COAPT trial, which sought to account for differences in the findings...

Data support use of AI to accurately estimate lesion-specific ischemia

Elucid, a developer of AI software to enable cardiovascular disease detection, has announced the pub...

Inovise gains breakthrough designation for non-invasive heart failure management system

Inovise Medical has announced that the US Food and Drug Administration (FDA) has granted breakth...

Occlutech announces completion of enrolment in study of atrial flow regulator in heart failure patients

Occlutech has announced the completion of patient enrolment in its pilot study to assess safety and ...

CRT 2021: DISRUPT CAD III sub-study shows efficacy of IVL in patients with longer lesions

A sub-analysis of the DISRUPT CAD III clinical trial, investigating use of Shockwave intravascul...

IVL is a safe and predictable tool against coronary calcium

After Shockwave Medical announced that its intravascular lithotripsy (IVL) technology received pre-m...

Terumo reaches agreement to acquire predictive analytics specialist Health Outcomes Sciences

Terumo Corporation has signed a definitive agreement to acquire all assets of Health Outcomes Scienc...

ACC.21 switches to a virtual-only meeting

The American College of Cardiology (ACC) has announced that its 70th annual scientific session, will...

Urgent action needed to address growing burden of heart failure

Urgent action is needed to address the growing burden of heart failure and the impact of COVID-1...

CRT 2021: Recre8 sub-analysis points to higher rate of clinically relevant bleeding in HBR patients during DAPT

A sub-analysis of the Recre8 trial, assessing patients at high bleeding risk (HBR) undergoing pe...

Study shows AI can “extend the reach” of echocardiographic assessment

Caption Health has announced the publication of a study in JAMA Cardiology assessing its artific...

OpSens gains CE mark for OptoWire III

OpSens has received CE mark approval for the OptoWire III, the latest generation of its flagship pro...

MRI study of COVID-19 patients with raised troponin levels reveals high rate of heart damage

Around 50% of patients who have been hospitalised with severe COVID-19 and have raised levels of...

What role will remote robotic procedures play in the future of PCI?

With the COVID-19 pandemic creating new barriers to the accessibility of healthcare, the success...

Teleflex completes enrolment in CTO-PCI IDE study

Teleflex has announced the completion of patient enrolment in a clinical study evaluating the perfor...

Shockwave IVL receives US FDA pre-market approval for severely calcified coronary artery disease

Shockwave Medical has announced that its intravascular lithotripsy (IVL) technology has received pre...

Ticagrelor monotherapy associated with a lower bleeding risk than standard DAPT after PCI

Dropping aspirin shortly after percutaneous coronary intervention (PCI) is associated with lower...

Substantial reduction in tricuspid regurgitation reported in 30-day outcomes of CLASP TR study of Pascal device

A study detailing early experience of the Pascal transcatheter valve system (Edwards Lifescience...

Off-pump CABG “an effective option” for patients with reduced ejection fraction

Off-pump coronary artery bypass grafting (OPCABG) is a safe and effective option for the treatment o...

Global heart failure cases soar since 1990

The number of patients with heart failure worldwide nearly doubled from 33.5 million in 1990 to 64.3...

Robotic treatment starts with the heart

Robotic-assisted treatment is on the cusp of achieving its full potential, says J Aaron Grantham, co...

New recommendations issued on antithrombotic treatment of AF patients undergoing PCI

Updated recommendations on the optimal antithrombotic treatment of patients with atrial fibrillation...

Meta-analysis points to “inverse” relationship between TAVI centre volume and outcomes

The authors of a systematic review and meta-analysis, looking at the effect of institutional tra...

First patient enrolled in SUCCESS PTA post-market study of Selution drug-eluting balloon

MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its large post-market study...

iVascular announces availability of Angiolite DES for longer lesions

iVascular has announced that its Angiolite drug-eluting stent (DES) is available 44mm and 49mm lengt...

Philips completes acquisition of cardiac diagnostics specialist BioTelemetry

Royal Philips has announced that it has completed the acquisition of BioTelemetry, a US provider of ...

Puzzle Medical receives breakthrough designation for its transcatheter pump device

Puzzle Medical has announced that the US Food and Drug Administration (FDA) has granted the company ...

First European patient treated with Diamondback 360 coronary orbital atherectomy system

Cardiovascular Systems has announced that the first patient in Europe has been treated with its ...

COVID-19 patients at greater risk of death after cardiac arrest

COVID-19 patients who suffer a cardiac arrest either in or out of hospital are far more likely to di...

Rate of target vessel failure “significantly lower” after IVUS-guided PCI

Drug-eluting stent implantation guided by intravascular ultrasound (IVUS) is associated with signifi...

Study documents “surprisingly benign” impact of COVID-19 among cardiac surgery patients

A study published in the Journal of Cardiac Surgery, detailing 18 out of a group of 19 patients who ...

Minimally invasive aortic valve surgery or TAVI: The need for randomised trials

Minimally invasive aortic valve replacement (miAVR) in select patients with severe aortic stenos...

Comparative study reports favourable outcomes for VasoStat haemostasis device

Forge Medical has announced the publication of results of an investigator-initiated randomised trial...

STS 2021: Risk of burnout “a growing concern” in cardiothoracic surgery

The risk of burnout among cardiothoracic surgeons has been heightened by the COVID-19 pandemic, ...

STS 2021: Sean C Grondin elected STS president

Cardiothoracic surgeon Sean C Grondin from the University of Calgary (Calgary, Canada) has been elec...

STS 2021: Five-year COMMENCE results favour Resilia tissue aortic valve

Five-year data from the COMMENCE clinical trial, presented at the 57th annual meeting of the Soc...

STS 2021: Study identifies significant gender disparities in CABG

Women are significantly less likely than men to undergo coronary artery bypass grafting (CABG) using...

STS 2021: Cardiothoracic surgery suffers due to COVID-19

The COVID-19 pandemic has caused a substantial decline in overall heart surgery volume in the US...

STS 2021: Study of Impella 5.5 reports 79% survival rate at explant

A study of 356 patients treated with Impella 5.5 with SmartAssist (Abiomed) at 16 US and German cent...

Analysis of ADAPT-DES registry grades risk of stent thrombosis after PCI

An analysis of data from the ADAPT-DES registry, published in JACC: Cardiovascular Interventions, in...

Ancora Heart enrols first patient in the CORCINCH-HF study

Ancora Heart has announced enrolment of the first patient in the CORCINCH-HF pivotal trial, whic...

EU patients enrolled in REVERSE-IT trial of bentracimab for reversal of antiplatelet effects of ticagrelor

PhaseBio Pharmaceuticals has expanded its pivotal phase 3 REVERSE-IT trial for bentracimab into the ...

Cardiovascular News 60 – February 2021: OUS Edition

In this issue: Long-term registry data show TAVI has overtaken surgical aortic valve replacemen...

Cardiovascular News 60 – February 2021: US Edition

In this issue: Long-term registry data show TAVI has overtaken surgical aortic valve replacemen...

SIS Medical announces publication of results of ISAR-CALC study for its high-pressure balloon catheter

SIS Medical has announced the publication of the ISAR-CALC—ComparIson of Strategies to PrepAre SeveR...

Scoring systems may overstate risk of minimally invasive aortic valve procedures

Current scoring systems used to assess the risk of mortality in minimally invasive aortic valve ...

NHS England mandates adoption of HeartFlow analysis for coronary heart disease

HeartFlow has announced that National Health Service England (NHSE) and NHS Improvement have man...

Study backs biopolymer used in Foldax’s Tria valve

Tria
Foldax has today announced publication of a research paper in Advanced NanoBiomed Research that ...

Alleviant Medical receives FDA breakthrough designation for transcatheter technology

Alleviant Medical has announced that the US Food and Drug Administration (FDA) has granted the compa...

Aktiia’s wrist-mounted blood pressure monitor gains CE mark

Aktiia has announced that its automated blood pressure monitoring system has received the CE mar...

Social determinants key in assessing coronary heart disease risk

A patient’s risk of coronary heart disease may be more accurately predicted by taking into accou...

Patients “fearful” of seeking cardiac care during pandemic

Analysis of data from English hospitals suggests that there was a sharp decline in the number of peo...

“A huge loss to the cardiology community”: Tributes paid to Prof David Foley

Tributes have been paid to David Foley, professor of Interventional Cardiology at Beaumont Hospital,...

Diamondback 360 atherectomy system gains CE mark

Cardiovascular Systems has received the CE mark for its Diamondback 360 coronary orbital atherec...

Elixir Medical announces treatment of first patient in BIOADAPTOR trial

Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced that...

Abbott receives expanded Medicare reimbursement for MitraClip

Abbott has announced that the US Centers for Medicare & Medicaid Services (CMS) has revised ...

Occlutech’s atrial flow regulator receives breakthrough designation for heart failure patients

Occlutech has announced that the US Food and Drug Administration (FDA) has granted a breakthrough de...

“This is the tip of the iceberg” warns BHF as cardiothoracic surgeries cancelled

The British Heart Foundation (BHF) has warned of the potentially dire consequences caused by the mas...

iVascular announces 6mm maximum overexpansion capacity for Angiolite DES

iVascular has announced that its Angiolite drug-eluting stent (DES) offers a 6mm overexpansion capac...

Complete revascularisation achieved in one quarter of patients with acute MI complicated by cardiogenic shock

Complete revascularisation is rarely achieved in patients with multivessel coronary artery disea...

First remote robotic-assisted PCI completed in Europe using R-One platform

Robocath has announced the successful completion of the first remote robotic-assisted percutaneo...

The Foundry announces first-in-human procedure in study of Half Moon TMVR device

The Foundry today announced the completion of the first-in-human procedure with the Half Moon Medica...

Inari Medical’s FlowTriever receives FDA clearance for treatment of right atrial clot in transit

Inari Medical has announced US Food and Drug Administration (FDA) 510(k) clearance of the FlowTrieve...

Medtronic gets Health Canada approval for use of Evolut in low-risk aortic stenosis patients

Medtronic Canada has received a new expanded indication from Health Canada for its Evolut transc...

ACC.21 to offer remote COVID-19 screening

The American College of Cardiology (ACC) is partnering with BioIntelliSense, a continuous health mon...

CathWorks raises funds to support commercialisation of FFRangio system

CathWorks reported the completion of a US$30 million Series D financing round, proceeds from whi...

“Change in culture” needed to increase RCTs in cardiothoracic surgery

Specialists in congenital and adult cardiac and thoracic surgery have called for a cultural chan...

David J Cohen joins CRF as director of clinical and outcomes research

The Cardiovascular Research Foundation (CRF) has announced today David J Cohen has joined the or...

Acute heart failure patients see mortality risk double with COVID-19

Patients with acute heart failure nearly double their risk of dying if they get COVID-19, accord...

Ultromics receives FDA clearance for EchoGo Pro

The US Food and Drug Administration (FDA) has cleared the use of EchoGo Pro an aritificial intel...

CorWave secures €35 million investment

CorWave has rasied €35 million to fund the next stages of its development. The capital increase is s...

Heart failure specialist joins ALIVE Trial of Revivent transcatheter system

BioVentrix has announced that heart failure specialist Jerry Estep (Cleveland Clinic, Cleveland,...

VDYNE secures funding for studies of tricuspid valve replacement device

VDYNE has announced today that it has secured a US$21 million Series C financing, proceeds of which ...

ADVERTORIAL: What does SCOPE II tell us about TAVI device trials?

This advertorial is sponsored by Boston Scientific Results of the SCOPE II clinical trial wer...

Jian’an Wang named as editor of JACC: Asia

Jian’an Wang (Heart Center, Zhejiang University, Hangzhou, China) has been named the inaugural edito...

First US patient treated in trial of Harpoon mitral valve repair system

Edwards Lifesciences has announced that the first patient has been treated in the RESTORE clinic...

Sharing international insight to improve the cardiovascular treatment pathway

Michael Poon (Lenox Hill Hospital-Northwell Health, New York, USA) discusses the progress made in tr...

Sapien 3 valve approved for treatment of severe symptomatic aortic stenosis in Canada

Sapien 3
Edwards Lifesciences has announced that Health Canada has approved the expanded use of the Edwar...

Abbott’s HeartMate 3 LVAD receives approval for paediatric use

Abbott has announced that the US Food and Drug Administration (FDA) has approved updated labelli...

Analysis of STEMI patients finds little difference between prasugrel and ticagrelor after PCI

A subgroup analysis of the ISAR REACT-5—Intracoronary Stenting and Antithrombotic Regimen: Rapid Ear...

New valvular heart disease guidelines recognise expanding role of TAVI

New joint clinical practice guidelines on the treatment of patients with valvular heart disease have...

MagicTouch SCB granted breakthrough designation for the treatment of small coronary artery lesions

Concept Medical has been granted "Breakthrough Device Designation" from the Center for Devices and R...

Optimising pharmacology after transcatheter aortic valve replacement: Lessons from the POPular TAVI trial

Writing for Cardiovascular News, Harold Dauerman, Rony Lahoud and Newton Phuong from the Univers...

Investigational device exemption granted for Tria biopolymer mitral valve

Tria
Foldax has announced that the US Food and Drug Administration (FDA) has granted investigational devi...

Paying patients less likely to develop complications after cardiac surgery

Paying patients are 20% less likely than NHS patients to die or develop major complications, suc...

Abiomed completes first stage in early feasibility study of ECP heart pump

Abiomed has announced that its Impella ECP heart pump has completed the first stage in its US Food a...

CardioFlux imaging system granted Breakthough Device Designation

Genetesis has announced that its flagship product, CardioFlux, has been granted Breakthrough Device ...

ACC partners with Amgen and Veradigm on TRANSFORM: ACS study

The American College of Cardiology (ACC) will collaborate with Amgen and Veradigm on a study to ...

Corindus announces global launch of technIQ procedural automation series for CorPath GRX system

Corindus has announced today global launch of a new set of automated robotic movements in the te...

European launch for Acutus Medical’s AcQCross transseptal crossing system

Acutus Medical has announced CE mark approval and the European launch of its integrated family of tr...

Leaders in cardiothoracic surgery to consider impact of COVID-19 on the field

Global leaders in the field of cardiothoracic surgery will debate the impact of the COVID-19 pandemi...

Abbott launches virtual reality training programme for cardiologists using OCT imaging technology

Abbott has announced the global release of its first virtual reality-based training programme design...

Enrolment in Dan-NICAD II study of non-invasive diagnostic testing system completed

Acarix has announces the enrolment of the final patient in the Dan-NICAD II study of non-invasiv...

Staged strategy may be associated with improved outcomes when treating mitral regurgitation post-TAVI

The first international registry of patients undergoing transcatheter mitral interventions after tra...

Pre-existing coronary arterial disease linked to higher rate of myocardial infarction in patients receiving MitraClip

Pre-existing coronary arterial disease (CAD) was associated with higher in‐hospital acute myocardial...

LivaNova reaches agreement to sell its heart valve business

LivaNova has entered into an agreement with investment firm Gyrus Captial whereby entities funde...

Cathy Gates named as ACC’s new CEO

Cathy Gates has been named as the new CEO of the American College of Cardiology (ACC), effective...

Cardiothoracic surgery “stifled” during COVID-19 pandemic

Reduced effectiveness of treatment and increased running costs are likely to have driven down the co...

VersaCross RF Transseptal device found to be efficient for TMVR procedures

Baylis Medical has announced the publication of data demonstrating procedural efficiency for Mit...

Scoring system stratifies “dual” risk in aortic stenosis patients

A study published in the Journal of the American College of Cardiology (JACC) has detailed a scoring...

Women face a higher risk of heart failure after STEMI

Woman patient
Women face a 20% increased risk of developing heart failure or dying within five years after their f...

Vectorius granted breakthrough designation for V-LAP left atrial pressure sensor

Vectorious Medical Technologies has announced that the US Food and Drug Administration (FDA) has gra...

Philips launches IntelliSpace Portal 12 with updated cardiology imaging

Philips has announced the next generation of its advanced visualisation workspace—IntelliSpace Porta...

Gore announces encouraging early results for its pulmonary valved conduit

Gore has announced encouraging clinical results from its early feasibility study evaluating the safe...

PCR Valves: CUTTING-EDGE registry provides first look at long-term data on surgical procedures after transcatheter valve failure

Long-term data on the outcomes of surgery after failed transcatheter edge-to-edge mitral valve r...

PCR Valves: MitraClip G4 shows positive results in EXPAND G4 study

Data from the EXPAND G4 study, evaluating the performance of the latest generation MitraClip (Ab...

PCR Valves: Eight-year findings of NOTION I trial show comparable rates of mortality and stroke for TAVI and surgical valve replacement

Eight-year findings from the NOTION I trial—the first all-comers trial to randomise low-risk pat...

“Positive outlook” for transcatheter edge-to-edge treatment of mitral regurgitation

Emerging data supports transcatheter techniques to treat primary mitral regurgitation, according...

PCR Valves: “Encouraging” early results from DragonFly transseptal mitral valve presented

Details of an early feasibility study of transcatheter mitral edge-to-edge repair using the Drag...

PCR Valves: Valve-in-valve replacement should be standard of care for high-risk patients

Two-year outcomes from the MITRAL trial, presented at PCR Valves e-course (22-24 November, virtu...

PCR Valves: EXPAND registry reports favourable outcomes compared to COAPT

One-year findings from the EXPAND registry, evaluating real-world use of newer-generation MitraC...

PCR Valves: ACTIVATION trial finds no difference in one-year mortality or rehospitalisation from PCI prior to TAVI

The first randomised trial comparing a course of pre-procedure percutaneous coronary interventio...

Already the gold standard? PCR Valves panellists probe accumulating TAVI evidence

Discussion during the first day of the PCR Valves e-course (22–24 November, virtual) centred on ...

Tributes paid following death of esteemed UK cardiologist Anthony Gershlick

University of Leicester and University Hospitals of Leicester NHS Trust (UHL), Leicester, UK have an...

3D-printed heart model could be used in preparation for surgical training

A study published in ACS Biomaterials Science & Engineering details the development of a 3D-prin...

Corvia completes randomisation in REDUCE LAP-HF II trial

Corvia has announced completion of randomisation in its REDUCE LAP-HF II global, pivotal trial. ...

Boston Scientific discontinues Lotus Edge TAVI device

Boston Scientific has announced a global recall of all unused inventory of its Lotus Edge transc...

AHA 2020: Sinomed announces positive safety and efficacy data from PIONEER III study

Sinomed has announced the presentation of data from its inter-continental PIONEER III study comp...

TAVI overtakes surgical aortic valve replacement in the USA

The volume of transcatheter aortic valve implantation (TAVI) procedures in the USA exceeded surg...

AHA 2020: AF detected more often in high risk patients recovering from cardiac surgery

Atrial fibrillation (AF) was detected up to 10 times more frequently in high risk patients recov...

AHA 2020: Patients taking statins experience similar side effects from placebos

Among patients who stopped taking statins due to side effects, researchers found the statin may ...

AHA 2020: One-month DAPT safe and feasible after stent placement

A one-month treatment of dual anti-platelet therapy (DAPT) is safe and as effective as a longer ...

AHA 2020: Ticagrelor not superior to clopidogrel in reducing severe complications after PCI

The use of ticagrelor was not superior to clopidogrel in the reduction of the rate of severe com...

AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves

The primary results from the RIVER Trial—Rivaroxaban for Valvular Heart disease and Atrial Fibri...

Transcatheter repair strategy for tricuspid regurgitation associated with improved outcomes

A pooled analysis of interventional studies assessing the feasibility, efficacy and clinical out...

Append Medical completes transcatheter implant-free LAA occlusion procedures

Append Medical, developer of the Appligator implant-free left atrial appendage (LAA) occlusion d...

Michael Reardon

A pioneer in the field of transcatheter aortic valve implantation (TAVI), Michael Reardon (professor...

Higher risk in heart valve procedures performed by early-career cardiothoracic surgeons

Heart valve procedures performed by cardiothoracic surgeons with 10 years of experience or less are ...

American Heart Association issues call for action on structural racism in cardiovascular care

Structural racism is a major cause of poor health and premature death from heart disease and stroke,...

Results from Onyx One Clear study published

Results of the Onyx One Clear study, evaluating the safety and effectiveness of one-month dual a...

First 1,000 patients treated with Impella 5.5 with SmartAssist

Abiomed has announced that the first 1,000 patients have been treated with the Impella 5.5 with Smar...

England’s first COVID-19 lockdown led to a significant drop in PCI procedures

A significant decline in percutaneous coronary intervention (PCI) procedures was seen in England...

Study draws link between physician payments and device selection

Payments from device manufacturers to physicians are likely to have a bearing on device selection in...

AstraZeneca receives EU approval for heart failure drug Forxiga

AstraZeneca’s Forxiga (dapagliflozin)—known as Farxiga—has been approved in the European Union (EU) ...

Ticagrelor may not be superior to clopidogrel in ACS patients undergoing PCI

The use of ticagrelor in patients with acute coronary syndrome (ACS) undergoing percutaneous coronar...

Recipients of MyoSeed research funding announced

MyoKardia has announced three awardees of the 2020 MyoSeeds research grant programme, who have been ...

The benefits of optical coherence tomography in the cath lab

Kevin Croce, director, Chronic Total Occlusion and Complex Percutaneous Coronary Intervention Pr...

Heart failure patients with COVID-19 at increased risk of death, JACC study finds

COVID-19 patients with a history of heart failure were associated with a longer duration of hospital...

Late-breaking science is alive and well despite the pandemic

Late-breaking science in interventional cardiology is alive and well despite the COVID-19 pandemic. ...

First patients treated with the Impella ECP heart pump

Abiomed has announced the treatment of the first two patients using the Impella ECP expandable percu...

Panel explores the unanswered questions around short duration DAPT

Mounting evidence over the safety and efficacy of shorter-term dual antiplatelet therapy (DAPT) ...

Foldax receives US FDA approval to expand clinical study of novel biopolymer aortic heart valve

Tria
Foldax has announced that the US Food and Drug Administration (FDA) has granted approval to expand t...

ESC events to continue digitally in 2021, society announces

The European Society of Cardiology (ESC) has announced that its full portfolio of congresses, teachi...

BioCardia shares early data from phase III CardiAMP cell therapy trial

BioCardia has announced the publication of data from the initial open-label roll-in cohort that serv...

Study assesses cardiac troponin elevation and presence of echocardiographic abnormalities in COVID-19 patients

A study published in the Journal of the American College of Cardiology (JACC) has identified differe...

US FDA approval for Abiomed’s Breethe OXY-1 system

The US Food and Drug Administration (FDA) has granted Abiomed a 510(k) clearance for an all-in-o...

Tricuspid annular dilatation predicts mortality in aortic stenosis patients undergoing TAVI

Tricuspid annular dilatation (TAD) is an independent predictor of all-cause mortality in patients wi...

ACC publishes consensus document on TAVI-related conduction disturbances

The American College of Cardiology (ACC) has published an expert consensus decision pathway on the m...

Research programme to probe causes of unexplained cardiac arrest

A research programme into understanding the underlying causes of unexplained cardiac arrest has rece...

Meta-analysis supports use of all-cause mortality in PCI versus CABG trials

A meta-analysis of 23 randomised clinical trials comparing percutaneous coronary intervention (P...

Raising the bar for competency in high-risk coronary procedures

Rhian E Davies (University of Washington Medical Center, Seattle, USA) discusses a recent paper ...

JACC journal series looks at impact of COVID-19 on cardiovascular health

The Journal of the American College of Cardiology (JACC) has issued a three-part focus seminar on CO...

OPTIMIZE IDE study of Svelte drug-eluting stent shared at TCT Connect 2020

Results of the OPTIMIZE IDE study, assessing the Svelte drug-eluting stent (DES) Integrated Delivery...

Biosensors gains CE mark approval for BioFreedom Ultra stent system

Biosensors has announced the award of a CE mark for BioFreedom Ultra drug-coated coronary stent syst...

TCT Connect 2020: CeloNova announces interim data from 14-day DAPT trial

CeloNova BioSciences has announced interim results from the randomised Trial of COBRA PzF Stenti...

TCT Connect 2020: Durable polymer DES non-inferior to biodegradable polymer stents in ACS patients

Results of the HOST-REDUCE-POLYTECH-ACS, presented at TCT Connect 2020 (14–18 October, virtual) ...

TCT Connect 2020: SOLVE-TAVI shows higher rate of stroke for balloon-expandable valve

One-year follow-up results of the randomised SOLVE-TAVI trial showed similar rates of all-cause deat...

TCT Connect 2020: Reduced mitral regurgitation achieved with next generation MitraClip

One-year clinical outcomes from the global EXPAND study, reporting on the use of the third generatio...

Cardiovascular News 59 – October 2020: US Edition

In this issue: POPular TAVI prompts call for aspirin-only antiplatelet strategy post-TAVI IV...

TCT Connect 2020: Disrupt CAD III meets safety and effectiveness endpoints

Shockwave Medical has announced that the coronary Investigational Device Exemption (IDE) study—Disru...

Cardiovascular News 59 – October 2020

In this issue: POPular TAVI prompts call for aspirin-only antiplatelet strategy post-TAVI IV...

TCT Connect 2020: Philips announces one-year results of DEFINE PCI

Royal Philips has announced one-year results of the DEFINE PCI study, presented at TCT Connect 2020 ...

TCT Connect 2020: XIENCE trials demonstrate non-inferiority of shorter-term DAPT regimens

Mehran TCT 2020
A shorter course of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (P...

TCT Connect 2020: MITHRAS trial finds interventional iASD closure non-superior to conservative therapy

Interventional closure of an iatrogenic atrial septal defect (iASD) driven by transcatheter mitral v...

TCT Connect 2020: REFLECT II trial assesses TriGuard 3 embolic protection device in TAVI patients

The REFLECT II randomised clinical trial evaluating the safety and efficacy of a cerebral embolic pr...

TCT Connect 2020: Acurate neo fails to meet non-inferiority compared to Evolut in SCOPE II trial

Findings of the SCOPE II clinical trial, which were presented during a late breaking trial sessi...

TCT Connect 2020: Impella-supported high-risk PCI associated with improvement of LVEF

An interim analysis of the Restore EF Study, presented at TCT Connect 2020 (14–18 October, virtu...

High-risk surgery patients vulnerable to cardiovascular diseases

One in five high-risk patients undergoing major non-cardiac surgery will develop one or more heart c...

TCT Connect 2020: Results demonstrate safety and procedural success of orbital atherectomy system

Cardiovascular Systems has announced the presentation of results from a large retrospective obse...

TCT Connect 2020: Primary PCI is preferable in COVID-19 positive patients with ST-Elevation

Initial findings from the North American COVID-19 ST-Segment Elevation Myocardial Infarction (NA...

Medtronic agrees to invest in TMVr device development

Medtronic has today announced a partnership with The Foundry—a medical device company incubator—to i...